The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Alan Tan, MD, discusses factors influencing the choice of immunotherapy plus tyrosine kinase inhibitor vs dual IO in patients ...

The LEAP-015 study is evaluating Merck's Keytruda and Eisai's Lenvima plus chemotherapy in certain types of gastroesophageal ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

BTIG research firm reiterated its Buy rating and $21.00 price target for INmune Bio Inc. (NASDAQ:INMB), currently trading at ...

Adam Thomas, known for his roles in Waterloo Road as Donte Charles and Emmerdale's Adam Barton, made his first screen appearance back in 2002 on BBC's Doctors. Since then, the 36-year-old actor ...

with disease progression on or after treatment with an EGFR-tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy. WILMINGTON, Del., December 08, 2024--Positive results from the AMPLIFY ...

The phase 2b REZILIENT1 trial of zipalertinib in EGFR+ non–small cell lung cancer met its overall response rate primary end point with a consistent safety profile. The phase 2b part of the REZILIENT1 ...